Empower Advisory Group
CRL icon

Empower Advisory Group’s Charles River Laboratories CRL Stock Holding History

Empower Advisory Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,193
Closed -$333K – 533
2025
Q2 		$333K Sell
2,193
-3,279
-60% -$437K ﹤0.01% 386
2025
Q1 		$824K Sell
5,472
-270,379
-98% -$45.3M ﹤0.01% 255
2024
Q4 		$50.9M Buy
275,851
+6,747
+3% +$1.3M 0.17% 112
2024
Q3 		$53M Sell
269,104
-3,497
-1% -$727K 0.18% 110
2024
Q2 		$56.3M Buy
272,601
+5,808
+2% +$1.32M 0.21% 102
2024
Q1 		$72.3M Buy
266,793
+10,597
+4% +$2.53M 0.27% 81
2023
Q4 		$60.6M Buy
256,196
+13,962
+6% +$2.75M 0.24% 95
2023
Q3 		$47.5M Buy
242,234
+22,516
+10% +$4.62M 0.21% 100
2023
Q2 		$46.2M Buy
219,718
+18,321
+9% +$3.65M 0.2% 115
2023
Q1 		$40.3M Buy
+201,397
New +$45.6M 0.18% 118

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Empower Advisory Group's CRL Position: Q3 2025 in Review

Empower Advisory Group sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 2,193 shares — an estimated $333K sold.

Empower Advisory Group first reported a position in CRL in Q1 2023 and held it in 10 quarters. The position peaked at $72.3M in Q1 2024. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Empower Advisory Group reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • Empower Advisory Group sold 2,193 Charles River Laboratories shares in Q3 2025, an estimated $333K.
  • Empower Advisory Group first reported a position in Charles River Laboratories in Q1 2023 and held it in 10 quarters.
  • Empower Advisory Group's Charles River Laboratories position peaked at $72.3M in Q1 2024.
  • 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Empower Advisory Group's 13F filing for Q3 2025, filed 14 Nov 2025.